CLINICAL_TRIALS
trial_result
· 2018-09-12
Clinical Trial Update: Enterotoxigenic Escherichia Coli (ETEC) ETVAX Vaccine Trial in Bangladesh [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial of the ETVAX vaccine for Escherichia coli diarrhea conducted in Bangladesh has completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PATH | Conditions: Escherichia Coli Diarrhea | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-09-12